Insider Transactions in Q3 2023 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2023
|
James M Frates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,165
+14.59%
|
$108,990
$6.88 P/Share
|
|
Aug 15
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
2,000,000
-28.58%
|
-
|
|
Aug 15
2023
|
Gina Mazzariello Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,164
-11.16%
|
$123,280
$20.88 P/Share
|
|
Jul 12
2023
|
Margaret Olinger Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.38%
|
$0
$0.37 P/Share
|